Julie N Graff
7PUBLICATIONS
102CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jan 05, 2026
Elevated Tumor-Associated Androgen Receptor Activity Correlates with Poor Immune Infiltration and Immunotherapy Response across Cancer Types.Ya-Mei Hu, Faming Zhao, Julie N Graff
|Oct 23, 2025
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations.David J Einstein, Melissa L Abel, Jeanny B Aragon-Ching
|Oct 07, 2025
Niraparib and abiraterone acetate plus prednisone for HRR-deficient metastatic castration-sensitive prostate cancer: a randomized phase 3 trial.Gerhardt Attard, Neeraj Agarwal, Julie N Graff
|Feb 18, 2025
Clinical and Translational Results from PORTER, a Multicohort Phase I Platform Trial of Combination Immunotherapy in Metastatic Castration-Resistant Prostate Cancer.Matthew D Galsky, Karen A Autio, Christopher R Cabanski
|Dec 09, 2024
Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer.Lisa N Chesner, Fanny Polesso, Julie N Graff
|May 28, 2021
KEYNOTE-641: a Phase III study of pembrolizumab plus enzalutamide for metastatic castration-resistant prostate cancer.Julie N Graff, Li Wen Liang, Jeri Kim
Pageof 2
Frequent Collaborators
3 joint publications
Amy E Moran
3 joint publications
Zheng Xia
3 joint publications
Faming Zhao
3 joint publications
Ya-Mei Hu
2 joint publications
Karen A Autio
2 joint publications
Jinho Lee
2 joint publications
Yi Zhang
2 joint publications
Joshi J Alumkal
2 joint publications
Jayne M Stommel
2 joint publications
Canping Chen
